摘要
幽门螺旋杆菌(Helicobacter pylori,Hp)是一类广泛定植于胃粘膜的微需氧革兰阳性杆菌,同慢性胃炎、消化性溃疡、胃粘膜萎缩、肠化生、上皮内瘤变及粘膜相关淋巴瘤等疾病相关。以往经典的"序贯疗法""伴同疗法""三联方案"随着抗菌药物耐药性的增高成功率逐渐下降,探究幽门螺旋杆菌感染的治疗方法的最新进展情况非常重要。现重点结合2016年全国幽门螺杆菌感染处理共识及部分国外研究成果对有关幽门螺旋杆菌治疗方法最新进展情况予以阐述。
Helicobacter pylori(Hp) is a kind of micro aerobic Gram-positive bacilli which are widely distributed in gastric mucosa. It is associated with chronic gastritis, peptic ulcer, gastric mucosal atrophy, intestinal metaplasia,intraepithelial neoplasia and mucosa associated lymphoma.In the past, the sequential therapy of "sequential therapy", "the same therapy" and "triple program" are gradually decreased along with the increase of antibiotic resistance. It is very important to explore the latest progress in the treatment of Helicobacter pylori infection.It is explained the latest progress in the treatment of Helicobacter pylori focus on the common understanding of the treatment of Helicobacter pylori infection and some foreign research results in 2016.
出处
《影像研究与医学应用》
2018年第8期3-4,共2页
Journal of Imaging Research and Medical Applications
关键词
幽门螺旋杆菌
治疗方法
最新进展
Helicobacter pylori
Treatment methods
Recent progress
